- (
) Incisionless surgery for heartburn goes for the throat
"The quality of life issues related to reflux really can be severe. In fact, GERD can lead to the development of a need for a lung transplant, and we see that all the time. They're [breathing in stomach acids] and they're scarring and then the lungs don't work ... [and] reflux disease is a big risk factor, the main risk factor, for esophageal cancer, which is a lethal disease."Most reflux patients, however, don't develop that cancer. Only about 1 percent or fewer appear to get esophageal cancer.
Dr. Jobe diagnosed Mrs. Crawford's complication as probable adult-onset asthma. More important, he also provided what is, if its short track record holds up, a cure for both the heartburn and the asthma.
It's a brand-new incisionless surgery he helped to pioneer in the United States called transoral incisionless endoscopic fundoplication, or EsophX. More>>
- (
) Zacks Industry Rank Analysis Highlights: Abbot Laboratories
AstraZeneca, which makes the acid reflux drug Nexium, is not expected to report until early November. Within the past few weeks, however, 2 of the 8 covering brokerage analysts raised their full-year forecasts. The revisions have pushed the consensus earnings estimate 4 cents higher to $4.85 per share.ViroPharma will report next Wednesday, Oct 29. Ahead of the report, 3 of the 9 covering brokerage analysts have raised their third-quarter forecasts. The revisions, however, were not large enough to move the consensus earnings estimate, which continues to sit at 23 cents per share.
As part of its earnings release, VPHM could provide an update on Cinryze, which treats angioedema attacks (swelling underneath the skin). The company received FDA approval 2 weeks ago and is expected to launch the drug this quarter. More>>
- (
) Diary of a reluctant drinker (and a lazy cook)
It's not just the acid reflux that kicks in after the second bottle of rough red, it's the next day's haze.Pathetic really - a wine scribe put off by a little morning-after fug. Wine wimp more like.
Not that I constrict myself to wine, you understand.
Some Monteith's Porter Dark Ale - as thick as treacle and with a decent sort of a boot (6%) on it - arrived through the post the other day; quite tasty too, but brilliant in a lamb stew.
Stick around and I might give you the recipe, not that I ever use recipes.
When, as a matter of principle, you ration yourself to 30 mins max food prep time, recipes just get in the way.
Cook by the seat of your pants, I say. Less anal; more fun. Because, apart from anything else, you never know quite how it's going to turn out. More>>
- (
) Beware of Congress’s Threat to Tax 401Ks
The Democrats' move comes as investor fear is rampant, as investors have been experiencing increasing acid reflux ever since the subprime crisis went viral in August 2007.Wall Street is witnessing gigantic swings never before seen in the history of the stock market, with the S&P 500 Options Volatility Index (the VIX) repeatedly breaking through the unheard of 80 barrier, twice the 40 levels that were unthinkable even when oil hit $147 a barrel this past summer-making a VIX 50 the new VIX 40.
Congress's Support of Taxing 401Ks
House Democrats several weeks ago invited Teresa Ghilarducci, a professor at the New School of Social Research in New York City, to testify before Congress on her plan to eliminate the preferential tax treatment of 401K plans. More>>
- (
) Santarus, Inc. (F3Q08) Earnings Call Transcript
The study evaluated the effective chronic morning PPI dosing on 24-hour gastric acid control in patients with symptoms of GERD. The result showed that the control of gastric acid is measured as the time gastric ph was greater than 4 was 14.3 hours for patients taking ZEGERID compared with 11.7 hours for patients treated with Prevacid. A significant difference with a Ph-value of 0.005 and 10 hours for patients treated with Protonix, again, a significant difference with a Ph-value of less than 0.001.In addition to our longer duration of acid control ZEGERID also reach the ph greater than 4 in 20 minutes, which was significantly faster than Prevacid and Protonix. This data showing ZEGERIDs acid control in the daytime adds to our previous two clinical studies that demonstrated ZEGERID's ability control acid when taken at night on an empty stomach. More>>